CoChat

Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient

Open access

The DOI matches its Crossref record; 166 of the 167 references it cites were found in a registry or an index.

Abstract

Major depressive disorder is an often chronic and recurring illness. Left untreated, major depressive disorder may result in progressive alterations in brain morphometry and circuit function. Recent findings, however, suggest that pharmacotherapy may halt and possibly reverse those effects. These findings, together with evidence that a delay in treatment is associated with poorer clinical outcomes, underscore the urgency of rapidly treating depression to full recovery. Early optimized treatment, using measurement-based care and customizing treatment to the individual patient, may afford the best possible outcomes for each patient. The aim of this article is to present recommendations for using a patient-centered approach to rapidly provide optimal pharmacological treatment to patients with major depressive disorder. Offering major depressive disorder treatment determined by individual patient characteristics (e.g., predominant symptoms, medical history, comorbidities), patient preferences and expectations, and, critically, their own definition of wellness provides the best opportunity for full functional recovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ijnp/pyx081

Cites

166 of 166 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Early optimized treatment is critical to bringing patients to full symptomatic and functional recovery. From (Habert et al., 2016).
Figure 1. Early optimized treatment is critical to bringing patients to full symptomatic and functional recovery. From (Habert et al., 2016).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 166 references

Research works printed but not linked: 5

  1. American Psychiatric Association, 2013, Major depressive disorder, 160
  2. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA), 2011, Canadian ADHD Practice Guidelines
  3. Canadian Network for Mood and AnxietyTreatments, 2017, SwitchRx: switching antipsychotic medications
  4. Sheehan, 2000, Sheehan Disability Scale, 113
  5. Work Group on Major Depressive Disorder. Practice Guideline For the Treatment of Patients With Major Depressive Disorder, edition 3. American Psychiatric Association, 2010

Cited by

See all 104

Metadata

Authors
Oluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P.
Affiliations
  • University of Calgary (CA)
  • START Clinic (CA)
  • University of Toronto (CA)
  • University of British Columbia (CA)
  • Queen's University (CA)
  • University of Ottawa (CA)
Corresponding author
Oluboka, Oloruntoba J
Venue
International Journal of Neuropsychopharmacology
Published
2017-09-08
Volume
21
Issue
2
Pages
128-144
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2753506619
Cited by
104
References
167
Citations by year
2026: 9 · 2025: 15 · 2024: 3 · 2023: 8 · 2022: 27 · 2021: 14 · 2020: 11 · 2019: 12 · 2018: 5
FWCI
0.97
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Pfizer
  • Pfizer Canada
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
major depressive disorder, functional recovery, early treatment, pharmacotherapy, measurement-based care, personalized treatment, patient-centered care, treatment delay, brain morphometry, comorbidities, patient preferences
MeSH terms
Antidepressive Agents, Major Depressive Disorder, Humans, Patient-Centered Care, Patient Preference, Early Medical Intervention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient. https://app.cochat.ai/papers/10.1093/ijnp/pyx081
The paper
Oluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P. (2018). Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyx081

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.